4uiw - Revision history

OCA at 11:21, 9 May 2024

OCA — Thu, 09 May 2024 11:21:23 GMT

←Older revision		Revision as of 11:21, 9 May 2024
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4uiw]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UIW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4UIW FirstGlance]. <br>		<table><tr><td colspan='2'>[[4uiw]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UIW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4UIW FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=H1B:N-[1,1-BIS(OXIDANYLIDENE)THIAN-4-YL]-5-ETHYL-4-OXIDANYLIDENE-7-[3-(TRIFLUOROMETHYL)PHENYL]THIENO[3,2-C]PYRIDINE-2-CARBOXIMIDAMIDE'>H1B</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.73Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=H1B:N-[1,1-BIS(OXIDANYLIDENE)THIAN-4-YL]-5-ETHYL-4-OXIDANYLIDENE-7-[3-(TRIFLUOROMETHYL)PHENYL]THIENO[3,2-C]PYRIDINE-2-CARBOXIMIDAMIDE'>H1B</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4uiw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uiw OCA], [https://pdbe.org/4uiw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4uiw RCSB], [https://www.ebi.ac.uk/pdbsum/4uiw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4uiw ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4uiw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uiw OCA], [https://pdbe.org/4uiw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4uiw RCSB], [https://www.ebi.ac.uk/pdbsum/4uiw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4uiw ProSAT]</span></td></tr>
	</table>		</table>

OCA at 08:27, 22 March 2023

OCA — Wed, 22 Mar 2023 08:27:54 GMT

←Older revision		Revision as of 08:27, 22 March 2023
Line 3:		Line 3:
	<StructureSection load='4uiw' size='340' side='right'caption='[[4uiw]], [[Resolution\|resolution]] 1.73Å' scene=''>		<StructureSection load='4uiw' size='340' side='right'caption='[[4uiw]], [[Resolution\|resolution]] 1.73Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4uiw]] is a 1 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UIW OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4UIW FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4uiw]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UIW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4UIW FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=H1B:N-[1,1-BIS(OXIDANYLIDENE)THIAN-4-YL]-5-ETHYL-4-OXIDANYLIDENE-7-[3-(TRIFLUOROMETHYL)PHENYL]THIENO[3,2-C]PYRIDINE-2-CARBOXIMIDAMIDE'>H1B</scene>~~</td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=H1B:N-[1,1-BIS(OXIDANYLIDENE)THIAN-4-YL]-5-ETHYL-4-OXIDANYLIDENE-7-[3-(TRIFLUOROMETHYL)PHENYL]THIENO[3,2-C]PYRIDINE-2-CARBOXIMIDAMIDE'>H1B</scene></td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4uit\|4uit]], [[4uiu\|4uiu]], [[4uiv\|4uiv]], [[4uix\|4uix]], [[4uiy\|4uiy]], [[4uiz\|4uiz]]~~</td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4uiw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uiw OCA], [https://pdbe.org/4uiw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4uiw RCSB], [https://www.ebi.ac.uk/pdbsum/4uiw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4uiw ProSAT]</span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4uiw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uiw OCA], [~~http~~://pdbe.org/4uiw PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4uiw RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4uiw PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4uiw ProSAT]</span></td></tr>	+
	</table>		</table>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/BRD9_HUMAN BRD9_HUMAN]] May play a role in chromatin remodeling and regulation of transcription.	+	[https://www.uniprot.org/uniprot/BRD9_HUMAN BRD9_HUMAN] May play a role in chromatin remodeling and regulation of transcription.
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 26:		Line 25:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Bamborough, P]]	+	[[Category: Bamborough P]]
-	[[Category: Chung, C]]	+	[[Category: Chung C]]
-	[[Category: Humphreys~~, P G~~]]	+	[[Category: Humphreys PG]]
-	[[Category: Theodoulou~~, N T]]~~	+	[[Category: Theodoulou NT]]
-	~~[[Category: Epigenetic reader]]~~	+
-	~~[[Category: Histone]]~~	+
-	~~[[Category: Inhibitor]]~~	+
-	~~[[Category: Transcription~~]]	+

OCA at 08:00, 21 May 2019

OCA — Tue, 21 May 2019 08:00:02 GMT

←Older revision		Revision as of 08:00, 21 May 2019
Line 1:		Line 1:

	==BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide==		==BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide==
-	<StructureSection load='4uiw' size='340' side='right' caption='[[4uiw]], [[Resolution\|resolution]] 1.73Å' scene=''>	+	<StructureSection load='4uiw' size='340' side='right'caption='[[4uiw]], [[Resolution\|resolution]] 1.73Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4uiw]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UIW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4UIW FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4uiw]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UIW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4UIW FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=H1B:N-[1,1-BIS(OXIDANYLIDENE)THIAN-4-YL]-5-ETHYL-4-OXIDANYLIDENE-7-[3-(TRIFLUOROMETHYL)PHENYL]THIENO[3,2-C]PYRIDINE-2-CARBOXIMIDAMIDE'>H1B</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=H1B:N-[1,1-BIS(OXIDANYLIDENE)THIAN-4-YL]-5-ETHYL-4-OXIDANYLIDENE-7-[3-(TRIFLUOROMETHYL)PHENYL]THIENO[3,2-C]PYRIDINE-2-CARBOXIMIDAMIDE'>H1B</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4uit\|4uit]], [[4uiu\|4uiu]], [[4uiv\|4uiv]], [[4uix\|4uix]], [[4uiy\|4uiy]], [[4uiz\|4uiz]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4uit\|4uit]], [[4uiu\|4uiu]], [[4uiv\|4uiv]], [[4uix\|4uix]], [[4uiy\|4uiy]], [[4uiz\|4uiz]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4uiw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uiw OCA], [http://pdbe.org/4uiw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4uiw RCSB], [http://www.ebi.ac.uk/pdbsum/4uiw PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4uiw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uiw OCA], [http://pdbe.org/4uiw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4uiw RCSB], [http://www.ebi.ac.uk/pdbsum/4uiw PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4uiw ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
Line 21:		Line 21:

	==See Also==		==See Also==
-	*[[Bromodomain-containing protein\|Bromodomain-containing protein]]	+	*[[Bromodomain-containing protein 3D structures\|Bromodomain-containing protein 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Bamborough, P]]		[[Category: Bamborough, P]]
	[[Category: Chung, C]]		[[Category: Chung, C]]

OCA at 20:06, 9 March 2016

OCA — Wed, 09 Mar 2016 20:06:56 GMT

←Older revision		Revision as of 20:06, 9 March 2016
Line 1:		Line 1:
		+
	==BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide==		==BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide==
	<StructureSection load='4uiw' size='340' side='right' caption='[[4uiw]], [[Resolution\|resolution]] 1.73Å' scene=''>		<StructureSection load='4uiw' size='340' side='right' caption='[[4uiw]], [[Resolution\|resolution]] 1.73Å' scene=''>
Line 5:		Line 6:
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=H1B:N-[1,1-BIS(OXIDANYLIDENE)THIAN-4-YL]-5-ETHYL-4-OXIDANYLIDENE-7-[3-(TRIFLUOROMETHYL)PHENYL]THIENO[3,2-C]PYRIDINE-2-CARBOXIMIDAMIDE'>H1B</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=H1B:N-[1,1-BIS(OXIDANYLIDENE)THIAN-4-YL]-5-ETHYL-4-OXIDANYLIDENE-7-[3-(TRIFLUOROMETHYL)PHENYL]THIENO[3,2-C]PYRIDINE-2-CARBOXIMIDAMIDE'>H1B</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4uit\|4uit]], [[4uiu\|4uiu]], [[4uiv\|4uiv]], [[4uix\|4uix]], [[4uiy\|4uiy]], [[4uiz\|4uiz]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4uit\|4uit]], [[4uiu\|4uiu]], [[4uiv\|4uiv]], [[4uix\|4uix]], [[4uiy\|4uiy]], [[4uiz\|4uiz]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4uiw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uiw OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4uiw RCSB], [http://www.ebi.ac.uk/pdbsum/4uiw PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4uiw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uiw OCA], [http://pdbe.org/4uiw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4uiw RCSB], [http://www.ebi.ac.uk/pdbsum/4uiw PDBsum]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
Line 17:		Line 18:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4uiw" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Bromodomain-containing protein\|Bromodomain-containing protein]]
	== References ==		== References ==
	<references/>		<references/>

OCA at 12:49, 22 April 2015

OCA — Wed, 22 Apr 2015 12:49:47 GMT

←Older revision		Revision as of 12:49, 22 April 2015
Line 1:		Line 1:
-	'''~~Unreleased~~ structure'''	+	==BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide==
		+	<StructureSection load='4uiw' size='340' side='right' caption='[[4uiw]], [[Resolution\|resolution]] 1.73Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[4uiw]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UIW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4UIW FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=H1B:N-[1,1-BIS(OXIDANYLIDENE)THIAN-4-YL]-5-ETHYL-4-OXIDANYLIDENE-7-[3-(TRIFLUOROMETHYL)PHENYL]THIENO[3,2-C]PYRIDINE-2-CARBOXIMIDAMIDE'>H1B</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4uit\|4uit]], [[4uiu\|4uiu]], [[4uiv\|4uiv]], [[4uix\|4uix]], [[4uiy\|4uiy]], [[4uiz\|4uiz]]</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4uiw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uiw OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4uiw RCSB], [http://www.ebi.ac.uk/pdbsum/4uiw PDBsum]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/BRD9_HUMAN BRD9_HUMAN]] May play a role in chromatin remodeling and regulation of transcription.
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Acetylation of histone lysine residues is one of the most well-studied post-translational modifications of chromatin, selectively recognized by bromodomain 'reader' modules. Inhibitors of the Bromodomain and Extra Terminal domain (BET) family of bromodomains have shown profound anti-cancer and anti-inflammatory properties, generating much interest in targeting other bromodomain-containing proteins for disease treatment. Herein, we report the discovery of I-BRD9, the first selective cellular chemical probe for Bromodomain-containing protein 9 (BRD9). I-BRD9 was identified through structure-based design, leading to greater than 700-fold selectivity over the BET family and 200-fold over the highly homologous Bromodomain-containing protein 7 (BRD7). I-BRD9 was used to identify genes regulated by BRD9 in Kasumi-1 cells involved in oncology and immune response pathways and to the best of our knowledge, represents the first selective tool compound available to elucidate the cellular phenotype of BRD9 bromodomain inhibition.

-	The ~~entry 4uiw is ON HOLD~~	+	The Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.,Theodoulou NH, Bamborough P, Bannister AJ, Becher I, Bit RA, Che KH, Chung CW, Dittmann A, Drewes G, Drewry DH, Gordon L, Grandi P, Leveridge M, Lindon M, Michon AM, Molnar J, Robson SC, Tomkinson NC, Kouzarides T, Prinjha RK, Humphreys PG J Med Chem. 2015 Apr 9. PMID:25856009<ref>PMID:25856009</ref>

-	~~Authors: Chung~~, C.~~, Theodoulou, N~~.~~T., Bamborough, P., Humphreys, P.G~~.	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-		+	</div>
-	~~Description: BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4-oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2-carboximidamide~~	+	== References ==
-	~~[[Category: Unreleased Structures]]~~	+	<references/>
-	[[Category: ~~Theodoulou~~, ~~N.T~~]]	+	__TOC__
		+	</StructureSection>
		+	[[Category: Bamborough, P]]
	[[Category: Chung, C]]		[[Category: Chung, C]]
-	[[Category: Humphreys, P.G]]	+	[[Category: Humphreys, P G]]
-	[[Category: ~~Bamborough~~, P]]	+	[[Category: Theodoulou, N T]]
		+	[[Category: Epigenetic reader]]
		+	[[Category: Histone]]
		+	[[Category: Inhibitor]]
		+	[[Category: Transcription]]

OCA: Protected "4uiw" [edit=sysop:move=sysop]

OCA — Wed, 15 Apr 2015 09:13:45 GMT

Protected "4uiw" [edit=sysop:move=sysop]

←Older revision

Revision as of 09:13, 15 April 2015

OCA: New page: '''Unreleased structure''' The entry 4uiw is ON HOLD Authors: Chung, C., Theodoulou, N.T., Bamborough, P., Humphreys, P.G. Description: BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-th...

OCA — Wed, 15 Apr 2015 09:13:44 GMT

New page: '''Unreleased structure''' The entry 4uiw is ON HOLD Authors: Chung, C., Theodoulou, N.T., Bamborough, P., Humphreys, P.G. Description: BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-th...

New page

'''Unreleased structure'''

The entry 4uiw is ON HOLD

Authors: Chung, C., Theodoulou, N.T., Bamborough, P., Humphreys, P.G.

Description: BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4-oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2-carboximidamide
[[Category: Unreleased Structures]]
[[Category: Theodoulou, N.T]]
[[Category: Chung, C]]
[[Category: Humphreys, P.G]]
[[Category: Bamborough, P]]